Acute Myeloid Leukemia Is Characterized by Wnt Pathway Inhibitor Promoter Methylation

被引:0
|
作者
Griffiths, Elizabeth A. [2 ]
Hooker, Craig M.
McDevitt, Michael A. [1 ]
Karp, Judith E. [2 ]
Herman, James G. [2 ]
Carraway, Hetty E. [2 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[2] Johns Hopkins Univ Hosp, Dept Oncol, Baltimore, MD 21287 USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:786 / 786
页数:1
相关论文
共 50 条
  • [1] Acute myeloid leukemia is characterized by Wnt pathway inhibitor promoter hypermethylation
    Griffiths, Elizabeth A.
    Gore, Steven D.
    Hooker, Craig M.
    McDevitt, Michael A.
    Karp, Judith E.
    Smith, B. Douglas
    Mohammad, Helai P.
    Ye, Ying
    Herman, James G.
    Carraway, Hetty E.
    LEUKEMIA & LYMPHOMA, 2010, 51 (09) : 1711 - 1719
  • [2] Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia
    Valencia, A.
    Roman-Gomez, J.
    Cervera, J.
    Such, E.
    Barragan, E.
    Bolufer, P.
    Moscardo, F.
    Sanz, G. F.
    Sanz, M. A.
    LEUKEMIA, 2009, 23 (09) : 1658 - 1666
  • [3] Wnt signaling pathway is epigenetically regulated by methylation of Wnt antagonists in acute myeloid leukemia
    A Valencia
    J Román-Gómez
    J Cervera
    E Such
    E Barragán
    P Bolufer
    F Moscardó
    G F Sanz
    M A Sanz
    Leukemia, 2009, 23 : 1658 - 1666
  • [4] Acute Myeloid Leukemia and the Wnt Pathway
    Eaves, Connie J.
    Humphries, R. Keith
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (24): : 2326 - 2327
  • [5] SOSTDC1 acts as a tumor inhibitor in acute myeloid leukemia by downregulating the Wnt/β-catenin pathway
    Li, Chengliang
    Wang, Minjuan
    Shi, Yingpeng
    Xin, Hong
    ENVIRONMENTAL TOXICOLOGY, 2022, 37 (08) : 1934 - 1943
  • [6] Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia
    Qian, Jun
    Qian, Zhen
    Lin, Jiang
    Yao, Dong-ming
    Chen, Qin
    Li, Yun
    Ji, Run-bi
    Yang, Jing
    Xiao, Gao-fei
    Wang, Ya-li
    LEUKEMIA RESEARCH, 2011, 35 (06) : 783 - 786
  • [7] WNT5A gene expression and promoter methylation in acute leukemia patients
    Hatimaz, O.
    Sayitoglu, M.
    Atalar, F.
    Erbilgin, Y.
    Ozbek, U.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 55 - 55
  • [8] ABERRANT METHYLATION OF WNT PATHWAY INHIBITORS AND ITS COOPERATION WITH OTHER GENETIC ALTERATIONS WITH DISTINCT CHARACTERISTICS IN ACUTE MYELOID LEUKEMIA
    Hou, H. -A.
    Chou, W. -C.
    Lin, L. -I.
    Chen, C. -Y.
    Tang, J. -L.
    Tseng, M. -H.
    Huang, C. -F
    Chiang, Y. -C.
    Yao, M.
    Wu, S. -J
    Huang, S. -Y.
    Ko, B. -S.
    Tsay, W.
    Chen, Y. C.
    Tien, H. -F
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 220 - 220
  • [9] Methylation status of galectin-12 gene promoter in acute myeloid leukemia
    Helbawi, Fatma M.
    Ahmed, Sohair M.
    Mahmoud, Maged S.
    Assem, Magda M.
    Kamal, Taghreed M.
    Abdou, Madleen Adel A.
    EGYPTIAN JOURNAL OF HAEMATOLOGY, 2021, 46 (01): : 1 - 6
  • [10] ABERRANT METHYLATION OF PROMOTER REGIONS OF SOX7, P15INK4B AND WNT PATHWAY ANTAGONIST GENES IN PATIENTS WITH ACUTE MYELOID LEUKEMIA
    Kostroma, I.
    Sidorova, Z.
    Gritsaev, S.
    Tiranova, S.
    Martinkevitch, I.
    Semenova, N.
    Chubukina, Z.
    Kapustin, S.
    Chechetkin, A.
    HAEMATOLOGICA, 2016, 101 : 674 - 675